Who owns Whitehawk Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of WHWK from SEC Form 13F filings across 59 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 59 institutions disclosed 20.5M shares of Whitehawk Therapeutics, Inc. worth $92.8M — about 24.7% of shares outstanding; the largest disclosed holder is QVT Financial LP. Source: SEC Form 13F filings, parsed by EvidInvest.
59
13F holders
$92.8M
value, 2026 filers
24.7%
of shares outstanding (20.5M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of WHWK's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | QVT Financial LP | 4.6M | $21.1M | 1.3% | 5.6% | 0.0% |
| 2 | MONTANOVA CAPITAL, LLC | 4.3M | $19.7M | 0.4% | 5.2% | +16.2% |
| 3 | ORBIMED ADVISORS LLC | 3.9M | $18.0M | 0.3% | 4.7% | -5.6% |
| 4 | BlackRock, Inc. | 1.9M | $8.8M | 0.0% | 2.3% | +447.2% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $6.4M | 0.0% | 1.7% | -47.2% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 899,780 | $4.1M | 0.0% | 1.1% | +96.7% |
| 7 | Woodline Partners LP | 436,614 | $2.0M | 0.0% | 0.5% | -22.4% |
| 8 | MILLENNIUM MANAGEMENT LLC | 380,406 | $1.7M | 0.0% | 0.5% | +22.8% |
| 9 | TWO SIGMA INVESTMENTS, LP | 296,612 | $1.4M | 0.0% | 0.4% | +8.5% |
| 10 | Balyasny Asset Management L.P. | 288,117 | $1.3M | 0.0% | 0.3% | -47.7% |
| 11 | NORTHERN TRUST CORP | 264,689 | $1.2M | 0.0% | 0.3% | +146.8% |
| 12 | VANGUARD FIDUCIARY TRUST CO | 246,907 | $1.1M | 0.0% | 0.3% | +14.9% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 219,217 | $1.0M | 0.0% | 0.3% | new |
| 14 | ACADIAN ASSET MANAGEMENT LLC | 170,883 | $778 | 0.0% | 0.2% | +143.8% |
| 15 | GOLDMAN SACHS GROUP INC | 126,758 | $580,552 | 0.0% | 0.2% | +122.7% |
| 16 | Bank of New York Mellon CorpNEW | 82,632 | $378,455 | 0.0% | 0.1% | new |
| 17 | Sixth Street Partners Management Company, L.P.NEW | 78,832 | $361,051 | 0.1% | 0.1% | new |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW | 78,832 | $361,051 | 0.0% | 0.1% | new |
| 19 | Point72 Asset Management, L.P. | 57,129 | $261,651 | 0.0% | 0.1% | +103.8% |
| 20 | AMERICAN CENTURY COMPANIES INCNEW | 51,840 | $237,427 | 0.0% | 0.1% | new |
| 21 | UBS Group AG | 50,841 | $232,851 | 0.0% | 0.1% | +344.5% |
| 22 | Qube Research & Technologies Ltd | 48,993 | $224,388 | 0.0% | 0.1% | +1.4% |
| 23 | Nuveen, LLCNEW | 43,799 | $200,599 | 0.0% | 0.1% | new |
| 24 | Jump Financial, LLCNEW | 40,800 | $186,864 | 0.0% | 0% | new |
| 25 | Invesco Ltd.NEW | 39,179 | $179,440 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.